Company intelligence / Profile preview

Scendea

Bishop's Stortford, United Kingdomscendea.com ↗

Ownership: Private
Employees: ~67
Development stage: Other

Overview

Scendea is an international product development and regulatory consulting group serving pharmaceutical and biotechnology companies. It provides strategic support in non-clinical development, CMC (chemistry manufacturing & controls), clinical strategy, and regulatory affairs to guide products efficiently from early-stage research through to marketing approval. The company has contributed expertise to over 1,000 development programs spanning more than 100 indications in 25 therapeutic areas.

Therapeutic areas: OncologyPulmonologyRare DiseasesInfectious Diseases
Modalities: Small moleculeMonoclonal antibodyBiologicRecombinant proteinCell therapyGene therapy
Industry: Consulting

Partnerships

No specific major pharma/biotech partnerships disclosed; collaborates broadly with pharmaceutical/biotech companies as clients

Beyond the preview

Go deeper on Scendea.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Scendea.

Explore the full profile